Parents will rise up against the cannabis industry: Fmr. NYT reporter
Alex Berenson, former reporter for the New York Times, discusses the risk around the cannabis craze and whether marijuana can catch on in the market place. Receive exclusive commentary from…
Cannabis stocks soar as other stocks tumble
CNBC’s Jane Wells takes a look at why cannabis stocks are faring better than much of the market. Steven DeAngelo has seen it all. As the so-called “father of the…
High times is responsible for the cannabis revolution: CEO
Transforming the cannabis culture, with Kraig Fox, High Times Holdings CEO. With CNBC’s Melissa Lee and the Fast Money traders, Tim Seymour, Steve Grasso, Karen Finerman and Dan Nathan. Subscribe…
Reddit attention helps spur cannabis stocks
CNBC’s Frank Holland reports on the action in Cannabis stocks as Reddit’s WallStreetBets crowds seems to spur the move higher. For access to live and exclusive video from CNBC subscribe…
Green Growth mulls takeover bid for Canadian cannabis company Aphria
CNBC’s Aditi Roy discusses Green Growth’s takeover bid of Canadian cannabis company Aphria following the country’s legalization of marijuana this year. Subscribe to CNBC: About CNBC: From ‘Wall Street’ to…
ETF Spotlight: Aurora cannabis hit by pandemic-related restrictions
CNBC’s Morgan Brennan takes a look at cannabis-focused ETFs and the dip in Aurora shares. For access to live and exclusive video from CNBC subscribe to CNBC PRO: Subscribe to…
Cannabis stocks in 2022: Top trends for investors to watch
Amplify Seymour Cannabis ETF (CNBS) portfolio manager Tim Seymour walks investors through the top trends to watch in the marijuana space in 2022 and beyond. For access to live and…
How illegal dispensaries are a threat to the legal cannabis industry
The booming business of cannabis is what many investors are calling the new gold rush. But with those potential riches comes this reality: there’s a much bigger boom in the…
U.S. vs. Canadian cannabis stocks: Key distinctions
Tim Seymour, who runs the Amplify Seymour Cannabis ETF (CNBS), explains the performance discrepancy between U.S. and Canadian pot stocks around U.S. elections. For access to live and exclusive video…
Hexo needs strategic options to compete in cannabis industry: Activist investor
Activist investor and Riposte Managing Partner Khaled Beydoun explains why he believes Canadian cannabis company Hexo can go higher.